DNA Methylation and Prospects for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy for Triple-Negative and Luminal B Breast Cancer

SIMPLE SUMMARY: Breast cancer (BC) is a group of diseases heterogeneous in morphology, progression, survival, and response to therapy. Although BC is among the most exhaustively studied cancers, there is still a lack of molecular markers to predict its response to neoadjuvant chemotherapy (NACT). Tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sigin, Vladimir O., Kalinkin, Alexey I., Nikolaeva, Alexandra F., Ignatova, Ekaterina O., Kuznetsova, Ekaterina B., Chesnokova, Galina G., Litviakov, Nikolai V., Tsyganov, Matvey M., Ibragimova, Marina K., Vinogradov, Ilya I., Vinogradov, Maxim I., Vinogradov, Igor Y., Zaletaev, Dmitry V., Nemtsova, Marina V., Kutsev, Sergey I., Tanas, Alexander S., Strelnikov, Vladimir V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001080/
https://www.ncbi.nlm.nih.gov/pubmed/36900421
http://dx.doi.org/10.3390/cancers15051630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001080/
https://www.ncbi.nlm.nih.gov/pubmed/36900421
http://dx.doi.org/10.3390/cancers15051630

Ejemplares similares